Jeffrey D. Marrazzo
Director/Board Member at PRIME MEDICINE, INC.
Profile
Jeffrey D.
Marrazzo was the founder of Spark Therapeutics, Inc. founded in 2013, where he held the title of Chief Executive Officer from 2019 to 2022.
He currently holds director positions at Biotechnology Innovation Organization, Prime Medicine, Inc. (since 2023), and Chroma Medicine, Inc. (since 2022).
Mr. Marrazzo's former positions include Member-Business Development at Tengion, Inc. (2008-2009), Senior Vice President-Business Development at Generation Health, Inc. (2009), and Chief Business Officer-US Division at Molecular Health, Inc. (2011-2013).
Mr. Marrazzo's education includes a graduate degree from Harvard University, an undergraduate degree from the University of Pennsylvania, and an MBA from The Wharton School of the University of Pennsylvania.
Jeffrey D. Marrazzo active positions
| Companies | Position | Start |
|---|---|---|
| PRIME MEDICINE, INC. | Director/Board Member | 2023-05-09 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Director/Board Member | 2022-10-03 |
Former positions of Jeffrey D. Marrazzo
| Companies | Position | End |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Founder | 2022-03-31 |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2012-12-31 |
Generation Health, Inc.
 Generation Health, Inc. Medical/Nursing ServicesHealth Services Generation Health, Inc. provides health management services focuses on genetic testing benefit management. The company was founded by Graham Gardner, J. Christian Kryder, Ricahrad K. Schatzberg, Per G. H. Lofberg, and David M. Margulies on September 23, 2008 and is headquartered in Upper Saddle River, NJ. | Corporate Officer/Principal | 2008-12-31 |
| TENGION, INC. | Corporate Officer/Principal | - |
Training of Jeffrey D. Marrazzo
| Harvard University | Graduate Degree |
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TENGION, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Generation Health, Inc.
Generation Health, Inc. Medical/Nursing ServicesHealth Services Generation Health, Inc. provides health management services focuses on genetic testing benefit management. The company was founded by Graham Gardner, J. Christian Kryder, Ricahrad K. Schatzberg, Per G. H. Lofberg, and David M. Margulies on September 23, 2008 and is headquartered in Upper Saddle River, NJ. | Health Services |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Technology Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Jeffrey D. Marrazzo
